In contrast, IDH-mutant (IDHmut) gliomas are characterized by lower lactate levels, and their epigenetic landscape is driven primarily by the oncometabolite D-2-hydroxyglutarate (D-2HG). The gene discussed is IDH1; the disease is central nervous system cancer.